ghk-cu hair growth evidence study Peptide for Growth: Science, Benefits, and How It Works ghk-cu hair growth evidence clinical

P O Box 97110, Manukau City, Manukau, 2241, New Zealand

The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)

MIC B12 injections do not address serious weight issues or obesity

10.1016/S0378-5173(00)00526-3 47

Both are taken as capsules

Athletes face suspension, disqualification, or other penalties if the peptide is detected in drug testing